Clinical Trial Site

Auchenflower 4066

1 studies enrolling now · 3 studies all time

What they study most

ALA Dehydratase Deficient Porphyria (ADP), ANCA-Associated Vasculitis, Acute Hepatic Porphyria, Acute Intermittent Porphyria, Acute Porphyria, Hereditary Coproporphyria (HCP), High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Porphyria, Acute Intermittent, Variegate Porphyria (VP)

Studies at this site

• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed
• ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP) — Completed